Patent · US Active

Quinoline derivatives and MELK inhibitors containing the same

US9120749B2 · kind B2 · utility

11Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 28, 2011
Grant dateSep 1, 2015
Priority date—
Expiry dateJul 28, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/4709
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention directs a compound represented by formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.